Xiaoning Wang

Xiaoning Wang

Auto-generated profile, based on publicly available information

Xiaoning Wang

Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2020 in Science
Verified
Journal Article
Open access
PDF file
SBSandhya Bangaru
Sandhya Bangaru
GOGabriel Ozorowski
Gabriel Ozorowski
HTHannah L. Turner
Hannah L. Turner
AAAleksandar Antanasijevic
Aleksandar Antanasijevic
DHDeli Huang
Deli Huang
AWAndrew Ward
Andrew Ward
Structure of a vaccine candidate: Much effort is being targeted at developing vaccines that will provide protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A trimeric spike protein that decorates the virus is a primary target of the host immune system and the focus of vaccine development. Bangaru et al. present the structure of a leading vaccine candidate: a full-length spike protein with some modifications aimed at enhancing stability that is formulated in polysorbate 80 detergent. The study confirms that the full-length immunogen is in a stable prefusion conformation and provides a basis for understanding immune responses to the vaccine. Science , this issue p. 1089

22 October 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
ZBZachary T. Berndsen
Zachary T. Berndsen
SCSrirupa Chakraborty
Srirupa Chakraborty
XWXiaoning Wang
Xiaoning Wang
CCChristopher A. Cottrell
Christopher A. Cottrell
JTJonathan L. Torres
Jonathan L. Torres
AWAndrew Ward
Andrew Ward
Significance: The HIV-1 Env “glycan shield” masks the surface of the protein from immune recognition, yet intrinsic heterogeneity defies a typical structure–function description. Using an integrated approach of cryo-EM, computational modeling, and mass spectrometry, we visualized the glycan shield structure in a new light. Our approach facilitated development of cryo-EM analysis methods and allowed for validation of models against experiment. Comparison of Env expressed in different cell lines revealed how subtle differences in composition impact glycan shield structure and affect the accessibility of epitopes on the surface, providing insights for vaccine design. Finally, time-resolved cryo-EM experiments uncovered how highly connected glycan clusters help stabilize the prefusion trimer, suggesting the glycan shield may function beyond immune evasion.

25 March 2021 in Viruses
Verified
Journal Article
Open access
PDF file
IBIeva Bagdonaite
Ieva Bagdonaite
ATAndrew Thompson
Andrew Thompson
XWXiaoning Wang
Xiaoning Wang
MSMax Søgaard
Max Søgaard
CFCyrielle Fougeoux
Cyrielle Fougeoux
HWHans Wandall
Hans Wandall
Enveloped viruses hijack not only the host translation processes, but also its glycosylation machinery, and to a variable extent cover viral surface proteins with tolerogenic host-like structures. SARS-CoV-2 surface protein S presents as a trimer on the viral surface and is covered by a dense shield of N-linked glycans, and a few O-glycosites have been reported. The location of O-glycans is controlled by a large family of initiating enzymes with variable expression in cells and tissues and hence is difficult to predict. Here, we used our well-established O-glycoproteomic workflows to map the precise positions of O-linked glycosylation sites on three different entities of protein S—insect cell or human cell-produced ectodomains, or insect cell derived receptor binding domain (RBD). In total 25 O-glycosites were identified, with similar patterns in the two ectodomains of different cell origin, and a distinct pattern of the monomeric RBD. Strikingly, 16 out of 25 O-glycosites were located within three amino acids from known N-glycosites. However, O-glycosylation was primarily found on peptides that were unoccupied by N-glycans, and otherwise had low overall occupancy. This suggests possible complementary functions of O-glycans in immune shielding and negligible effects of O-glycosylation on subunit vaccine design for SARS-CoV-2.

1 May 2020 in Cell Host & Microbe
Verified
Journal Article
Closed access
ATAndrew J. Thompson
Andrew J. Thompson
LCLiwei Cao
Liwei Cao
YMYuanhui Ma
Yuanhui Ma
XWXiaoning Wang
Xiaoning Wang
JDJolene K. Diedrich
Jolene K. Diedrich
JPJames C. Paulson
James C. Paulson

1 October 2021 in Analytical Chemistry
Verified
Journal Article
Closed access
SBSabyasachi Baboo
Sabyasachi Baboo
JDJolene K. Diedrich
Jolene K. Diedrich
SMSalvador Martínez-Bartolomé
Salvador Martínez-Bartolomé
XWXiaoning Wang
Xiaoning Wang
TSTorben Schiffner
Torben Schiffner
JYJohn Yates
John Yates

1 February 2018 in Journal of Proteomics
Verified
Journal Article
Closed access
XWXiaoning Wang
Xiaoning Wang
ZDZaian Deng
Zaian Deng
CHChuncui Huang
Chuncui Huang
TZTong Zhu
Tong Zhu
JLJiatao Lou
Jiatao Lou
YLYan Li
Yan Li